ALK and lung adenocarcinoma: For accurate diagnosis and treatment, a special staining method was applied to the lung adenocarcinoma tissue—immunohistochemical (IHC) staining to detect PD-L1 (Programmed death-ligand 1) and ALK (Anaplastic Lymphoma receptor tyrosine Kinase) mutation for our patient.